Atlas Trials

Study of Pharmacokinetics, Pharmacodynamics, Safety of BCD-131 Compared to Mircera and Aranesp in Healthy Volunteers

Clinical trial NCT02731469 · COMPLETED

Trial details

NCT number
NCT02731469
Sponsor
Biocad
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Reticulocyte Count
Start date
2016-06-15
Primary completion
2017-03-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.